Journal article · 2023 · Open access

A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity

Philippa Meiser, Moritz A. Knolle, Anna Hirschberger, Gustavo Pereira de Almeida, Felix Bayerl, Sebastian B. Lacher, Anna‐Marie Pedde, Sophie Flommersfeld, Julian Hönninger, Leonhard Stark, Fabian Stögbauer, Martina Anton and 11 more

Cancer Cell, 41(8), 1498–1515.e10 · Published 13 July 2023 · DOI 10.1016/j.ccell.2023.06.008

Open full textCite this paper

In brief

“A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity” is a 2023 journal article by Philippa Meiser and 22 co-authors, published in Cancer Cell. OpenAlex counts 222 citations as of 18 November 2026, which puts it in the top 2% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Cancer Cell.

Citations
222
Most cited in
2025 (86)
Field-weighted impact
20.88
References
83
Authors
23

Abstract

Type 1 conventional dendritic cells (cDC1) can support T cell responses within tumors but whether this determines protective versus ineffective anti-cancer immunity is poorly understood. Here, we use imaging-based deep learning to identify intratumoral cDC1-CD8+ T cell clustering as a unique feature of protective anti-cancer immunity. These clusters form selectively in stromal tumor regions and constitute niches in which cDC1 activate TCF1+ stem-like CD8+ T cells. We identify a distinct population of immunostimulatory CCR7neg cDC1 that produce CXCL9 to promote cluster formation and cross-present tumor antigens within these niches, which is required for intratumoral CD8+ T cell differentiation and expansion and promotes cancer immune control. Similarly, in human cancers, CCR7neg cDC1 interact with CD8+ T cells in clusters and are associated with patient survival. Our findings reveal an intratumoral phase of the anti-cancer T cell response orchestrated by tumor-residing cDC1 that determines protective versus ineffective immunity and could be exploited for cancer therapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Meiser, P., Knolle, M. A., Hirschberger, A., de Almeida, G. P., Bayerl, F., Lacher, S. B., Pedde, A., Flommersfeld, S., Hönninger, J., Stark, L., Stögbauer, F., Anton, M., Wirth, M., Wohlleber, D., Steiger, K., Buchholz, V. R., Wollenberg, B., Zielinski, C. E., Braren, R., . . . Böttcher, J. P. (2023). A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity. Cancer Cell, 41(8), 1498–1515.e10. https://doi.org/10.1016/j.ccell.2023.06.008

MLA 9

Meiser, Philippa, et al. “A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity.” Cancer Cell, vol. 41, no. 8, 2023, pp. 1498–1515.e10. https://doi.org/10.1016/j.ccell.2023.06.008.

Chicago

Meiser, Philippa, Moritz A. Knolle, Anna Hirschberger, Gustavo Pereira de Almeida, Felix Bayerl, Sebastian B. Lacher, Anna‐Marie Pedde, et al. 2023. “A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity.” Cancer Cell 41 (8): 1498–1515.e10. https://doi.org/10.1016/j.ccell.2023.06.008.

Harvard

Meiser, P. et al. (2023) ‘A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity’, Cancer Cell, 41(8), pp. 1498–1515.e10. doi:10.1016/j.ccell.2023.06.008.

IEEE

P. Meiser et al., “A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity,” Cancer Cell, vol. 41, no. 8, pp. 1498–1515.e10, 2023, doi: 10.1016/j.ccell.2023.06.008.

BibTeX

@article{meiser2023distinct,
  title     = {{A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity}},
  author    = {Meiser, Philippa and Knolle, Moritz A. and Hirschberger, Anna and de Almeida, Gustavo Pereira and Bayerl, Felix and Lacher, Sebastian B. and Pedde, Anna‐Marie and Flommersfeld, Sophie and Hönninger, Julian and Stark, Leonhard and Stögbauer, Fabian and Anton, Martina and Wirth, Markus and Wohlleber, Dirk and Steiger, Katja and Buchholz, Veit R. and Wollenberg, Barbara and Zielinski, Christina E. and Braren, Rickmer and Rueckert, Daniel and Knolle, Percy Alexander and Kaissis, Georgios A. and Böttcher, Jan P.},
  journal   = {Cancer Cell},
  year      = {2023},
  volume    = {41},
  number    = {8},
  pages     = {1498--1515.e10},
  doi       = {10.1016/j.ccell.2023.06.008},
  url       = {https://doi.org/10.1016/j.ccell.2023.06.008}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202388
20246161
20258686
20266767

Its field-weighted citation impact is 20.88: it has been cited 20.88 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses

  • cDC1
  • CD8+ T cells
  • tumor microenvironment
  • CXCL9
  • cross-presentation
  • tumor antigen presentation
  • anti-cancer immunity
  • T cell differentiation

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Meiser, P., Knolle, M. A., Hirschberger, A., de Almeida, G. P., Bayerl, F., Lacher, S. B., Pedde, A., Flommersfeld, S., Hönninger, J., Stark, L., Stögbauer, F., Anton, M., Wirth, M., Wohlleber, D., Steiger, K., Buchholz, V. R., Wollenberg, B., Zielinski, C. E., Braren, R., . . . Böttcher, J. P. (2023). A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity. Cancer Cell, 41(8), 1498–1515.e10. https://doi.org/10.1016/j.ccell.2023.06.008

How many times has this paper been cited?

222 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cancer Cell: sign in and open the full text from this page.

Who wrote this paper?

Philippa Meiser, Moritz A. Knolle, Anna Hirschberger, Gustavo Pereira de Almeida, Felix Bayerl, Sebastian B. Lacher, Anna‐Marie Pedde, Sophie Flommersfeld, Julian Hönninger, Leonhard Stark, Fabian Stögbauer, Martina Anton and 11 more.

What is the DOI of this paper?

10.1016/j.ccell.2023.06.008, permanently at https://doi.org/10.1016/j.ccell.2023.06.008. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.